Loading...
NPI 1457408064 · Bellevue, WA · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Steve Kim is a ophthalmology physician provider located in Bellevue, Washington. This profile covers 22 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Steve Kim |
| Address | 1750 112th Ave Ne |
| City | Bellevue |
| State | WA |
| ZIP | 98004 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | January 4, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.4M |
| Medicaid | $20 |
This provider’s business is essentially Medicare-driven: lifetime Medicare revenue is $3.4M while lifetime Medicaid revenue is $24, so the practice is effectively single‑payer with negligible Medicaid volume. Analysts should treat Medicaid risk/coverage as immaterial for this profile and focus payer management efforts on Medicare utilization and reimbursement dynamics.
Revenue is highly concentrated in a narrow set of intravitreal-treatment codes: the precomputed top 3 Medicare codes by revenue account for 77.9% of this provider’s total Medicare revenue. Those top three are J0178 ($2.1M, 62.1% of Medicare revenue), J2777 ($357.8K, 10.5%), and 67028 ($181.4K, 5.3%), which makes the practice’s financial performance sensitive to utilization and reimbursement for these specific procedures and products.
The code mix and dollars point to a retina-focused, injection‑centric ophthalmology operation: J0178 and J2777 are anti‑VEGF/intravitreal drug codes and 67028 is the isolated intravitreal injection procedure, indicating routine office‑based intravitreal therapy as the primary service line. Supporting services commonly used in retinal care — including 92134 (retinal imaging) and eye‑related E/M visits such as 99213 and 92014 — also appear in the top codes, consistent with ongoing medical management and imaging follow‑up rather than a purely surgical practice.
On competitive standing, the provider is a high‑volume national performer for select services: J0178 ranks #167 of 3204 providers (95th percentile) and is described as "notably above typical national volume," signaling a major player in aflibercept administration. 92134 is an "extreme outlier" (rank #580 of 26868, 98th percentile) which further indicates unusually high retinal imaging volume relative to peers and strengthens the interpretation of a retina‑centered practice.
Office visit volume is also elevated relative to peers, reflecting substantial ongoing patient management: 99213 appears with 783 claims and $50.9K in revenue and ranks #11216 of 457151 providers (98th percentile), described as "notably above typical national volume." This suggests a consistent throughput of follow‑up visits that accompany injection‑based treatment pathways.
The provider bills meaningful amounts for unclassified/compounded drug codes that merit payer attention: J3490 accounts for $168.3K (4.9% of Medicare revenue) with an average paid/claim of $1980 and ranks #948 of 2838 providers (66th percentile), while J7999 contributes $13.8K (0.4%). Payers should flag these line items for price benchmarking and prior‑authorization scrutiny given their atypical average paid/claim.
Surgical retina and advanced procedures are present but not dominant: higher‑complexity CPTs such as 67042 ($25K), 67108 ($12.6K), and 67036 ($9.4K) appear at much lower claim counts and mid‑to‑lower national ranks, indicating the practice performs some surgical or procedural retina work but remains primarily an injection/imaging center. This mix implies the practice pathway is centered on medical retina care with selective surgical interventions.
This is an established practice with long tenure: the NPI was enumerated on 2007-01-04 (~19 years ago), indicating nearly two decades of billing history. Combined with the concentrated, high‑rank volumes on specific retinal codes, the data depict a stable, mature service line focused on intravitreal therapeutics and retinal imaging rather than broad multispecialty ophthalmic care.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3,100 | $680 | $2.1M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 12,780 | $30 | $357.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,850 | $100 | $181.4K |
| J3490 | Unclassified drugs | 90 | $1,980 | $168.3K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 510 | $220 | $110.5K |
| J2778 | Injection, ranibizumab, 0.1 mg | 480 | $190 | $89.5K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,650 | $30 | $76.9K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 530 | $120 | $63K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 570 | $90 | $53.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 780 | $70 | $50.9K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J2777 | 26 | 50 | 12,780 | $30 | $599.7K |
| J0178 | 1 | 90 | 470 | $680 | $597.2K |
| Q5128 | 8 | 10 | 520 | $220 | $136.6K |
| J2778 | 15 | 30 | 510 | $180 | $117.1K |
| J2781 | 9 | 10 | 650 | $120 | $88.6K |
| 67028 | 12 | 110 | 550 | $90 | $72.9K |
| J3490 | 25 | 70 | 70 | $50 | $51.2K |
| J7312 | 13 | 20 | 270 | $160 | $46K |
| 67042 | 17 | 40 | 30 | $1,190 | $39.2K |
| 67108 | 15 | 20 | 20 | $1,180 | $29.6K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 30 | $0 | $0 |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 50 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Washington providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Washington median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 51 | 60 | 710 | $40 | $81.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 72 | 100 | 240 | $10 | $22.2K |
Other providers in the same ZIP code as Steve Kim, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.